Demo Sign up Log In

AgeX Therapeutics, Inc. (AGE)

Cash Conversion Ratio

0.58×

Quarterly · Period ending: Jun 30, 2025

AGE Cash Conversion Ratio

Latest reported0.58×period endingJun 30, 2025

Latest reported0.58×period endingJun 30, 2025

AGE Quarterly Cash Conversion Ratio (0.68× → 0.58×)

Latest values, visible window

High-resolution chart · PNG

AGE cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2025	0.5816×
Dec 31, 2024	1.6766×
Sep 30, 2024	-2.1028×
Mar 31, 2024	0.106×
Dec 31, 2023	0.0485×
Sep 30, 2023	-0.6524×
Jun 30, 2023	-1.4592×
Mar 31, 2023	-0.4276×
Dec 31, 2022	0.4887×
Sep 30, 2022	0.5076×
Jun 30, 2022	0.6669×
Mar 31, 2022	0.6046×
Dec 31, 2021	0.7632×
Sep 30, 2021	0.9637×
Jun 30, 2021	0.6847×
Mar 31, 2021	1.2596×
Dec 31, 2020	0.6623×
Sep 30, 2020	0.7475×
Jun 30, 2020	0.836×
Mar 31, 2020	0.6489×
Dec 31, 2019	0.9982×
Sep 30, 2019	0.81×
Jun 30, 2019	0.9275×
Dec 31, 2018	0.6422×
Sep 30, 2018	0.8322×
Jun 30, 2018	1.1249×
Mar 31, 2018	8.5489×
Dec 31, 2017	1.4035×
Sep 30, 2017	0.2958×
Jun 30, 2017	3.0616×
Mar 31, 2017	0.6811×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.